FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-8748com.
(The FASEB Journal. 2008;22:1144-1154.)
© 2008 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.07-8748comv1
22/4/1144    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Huet, E.
Right arrow Articles by Gabison, E. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huet, E.
Right arrow Articles by Gabison, E. E.
(The FASEB Journal. 2008;22:1144-1154.)
© 2008 FASEB

Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing {alpha}-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling

Eric Huet*, Benoit Vallée*, Dominika Szul*, Franck Verrecchia{dagger}, Samia Mourah{ddagger}, James V. Jester§, Thanh Hoang-Xuan||, Suzanne Menashi*,1 and Eric E. Gabison*,||

* CRRET Laboratory, CNRS UMR 7149, University of Paris XII, Créteil, France;

{dagger} INSERM U697 and

{ddagger} INSERM U716, Laboratoire de Pharmacologie, Hôpital Saint-Louis, Paris, France;

§ Department of Ophthalmology, University of California at Irvine, Irvine, California, USA; and

|| Department of Ophthalmology at Fondation Ophtalmologique A. de Rothschild and Bichat Hospital, AP-HP, Paris, France

1Correspondence: CRRET Laboratory, CNRS UMR 7149, University Paris XII, 61 Av du Général de Gaulle, 94010 Créteil Cedex, France. E-mail: menashi{at}univ-paris12.fr

Extracellular matrix metalloproteinase inducer (EMMPRIN) is a cell surface glycoprotein enriched on tumor cells and normal epithelia. It is mainly known for its ability to induce matrix metalloproteinase production in fibroblasts following epithelial-stromal interaction. We sought to examine whether EMMPRIN has a broader role promoting fibroblast-to-myofibroblast differentiation. Because {alpha}-smooth muscle actin ({alpha}SMA) is considered a marker of this differentiation process, we analyzed the effect of EMMPRIN on its expression in corneal and skin fibroblasts by Western blots, immunocytochemistry, and a functional assay of collagen lattice contraction. Increasing EMMPRIN expression by cDNA transfection or by treatment with exogenously added recombinant EMMPRIN resulted in an up-regulation of {alpha}SMA expression. EMMPRIN also increased the contractile properties of the treated fibroblasts as demonstrated by the immunohistochemical appearance of stress fibers and by the accelerated contraction of fibroblast-embedded collagen lattices. Blocking EMMPRIN expression by small interfering RNA inhibited {alpha}SMA and collagen gel contraction induced not only by EMMPRIN but also by transforming growth factor-β, a major mediator of myofibroblast differentiation that also regulated EMMPRIN expression. These findings, combined with the fact that EMMPRIN and {alpha}SMA colocalized to the same cells in the stroma of pathological corneas, expand on the mechanism by which EMMPRIN remodels extracellular matrix during wound healing and cancer.—Huet, E., Vallée, B., Szul, D., Verrecchia, F., Mourah, S., Jester, J. V., Hoang-Xuan, T., Menashi, S., Gabison, E. E. Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing {alpha}-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling.


Key Words: epithelial-stromal interactions • wound healing • MMPs • TGFβ







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.